Chronic treatment of human astrocytoma cells with lithium, carbamazepine or valproic acid decreases inositol uptake at high inositol concentrations but increases it at low inositol concentrations

Marina Wolfson, Yuli Bersudsky, Evgeny Zinger, Marina Simkin, R. H. Belmaker, Leif Hertz

Research output: Contribution to journalArticlepeer-review

42 Scopus citations

Abstract

Inositol uptake was measured at concentrations of 25, 40 and 50 μM in human astrocytoma cell cultures treated for 1-3 weeks with pharmacologically relevant concentrations of LiCl, valproic acid or carbamazepine as well as in control cultures that had not been treated with any drug. After at least 2 weeks of treatment, each of these 3 conventional anti-bipolar drugs increased the uptake significantly at 25 μM inositol, had no effect at 40 μM, and decreased it at 50 μM inositol. Reduction of the drug concentrations by 50% abolished the stimulation of uptake at 25 μM inositol by lithium and valproic acid and reduced that by carbamazepine. These findings may contribute to an understanding of the mechanisms of action for anti-bipolar medication, and explain the controversy in the literature whether or not brain inositol is reduced after chronic administration of lithium. (C) 2000 Published by Elsevier Science B.V.

Original languageEnglish
Pages (from-to)158-161
Number of pages4
JournalBrain Research
Volume855
Issue number1
DOIs
StatePublished - 7 Feb 2000

Keywords

  • Astrocyte
  • Bipolar disorder
  • Brain
  • Signaling mechanism

ASJC Scopus subject areas

  • General Neuroscience
  • Molecular Biology
  • Clinical Neurology
  • Developmental Biology

Fingerprint

Dive into the research topics of 'Chronic treatment of human astrocytoma cells with lithium, carbamazepine or valproic acid decreases inositol uptake at high inositol concentrations but increases it at low inositol concentrations'. Together they form a unique fingerprint.

Cite this